67 related articles for article (PubMed ID: 21153322)
1. Role of 4-1BBL and TRAF1 in the CD8 T cell response to influenza virus and HIV.
Watts TH; Lin GH; Wang C; McPherson AJ; Snell LM; Sabbagh L
Adv Exp Med Biol; 2011; 691():177-86. PubMed ID: 21153322
[No Abstract] [Full Text] [Related]
2. 4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection.
Zhou AC; Batista NV; Watts TH
J Immunol; 2019 Apr; 202(8):2482-2492. PubMed ID: 30867239
[TBL] [Abstract][Full Text] [Related]
3. Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8⁺ memory T cells in the bone marrow.
Lin GH; Edele F; Mbanwi AN; Wortzman ME; Snell LM; Vidric M; Roth K; Hauser AE; Watts TH
Eur J Immunol; 2012 Nov; 42(11):2861-74. PubMed ID: 22886791
[TBL] [Abstract][Full Text] [Related]
4. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells.
Wang C; Wen T; Routy JP; Bernard NF; Sekaly RP; Watts TH
J Immunol; 2007 Dec; 179(12):8252-63. PubMed ID: 18056369
[TBL] [Abstract][Full Text] [Related]
5. Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection.
Wang C; McPherson AJ; Jones RB; Kawamura KS; Lin GH; Lang PA; Ambagala T; Pellegrini M; Calzascia T; Aidarus N; Elford AR; Yue FY; Kremmer E; Kovacs CM; Benko E; Tremblay C; Routy JP; Bernard NF; Ostrowski MA; Ohashi PS; Watts TH
J Exp Med; 2012 Jan; 209(1):77-91. PubMed ID: 22184633
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
[TBL] [Abstract][Full Text] [Related]
7. 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine.
Harrison JM; Bertram EM; Boyle DB; Coupar BE; Ranasinghe C; Ramshaw IA
Vaccine; 2006 Nov; 24(47-48):6867-74. PubMed ID: 17050052
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease.
Moraes TJ; Lin GH; Wen T; Watts TH
Vaccine; 2011 Aug; 29(37):6301-12. PubMed ID: 21704101
[TBL] [Abstract][Full Text] [Related]
9. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.
Bukczynski J; Wen T; Ellefsen K; Gauldie J; Watts TH
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1291-6. PubMed ID: 14745033
[TBL] [Abstract][Full Text] [Related]
10. Development of a potent melanoma vaccine capable of stimulating CD8(+) T-cells independently of dendritic cells in a mouse model.
Powell KL; Stephens AS; Ralph SJ
Cancer Immunol Immunother; 2015 Jul; 64(7):861-72. PubMed ID: 25893808
[TBL] [Abstract][Full Text] [Related]
11. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo.
Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS
Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476
[TBL] [Abstract][Full Text] [Related]
12. GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology.
Lin GH; Snell LM; Wortzman ME; Clouthier DL; Watts TH
J Immunol; 2013 May; 190(9):4627-39. PubMed ID: 23536631
[TBL] [Abstract][Full Text] [Related]
13. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges.
Wang C; Lin GH; McPherson AJ; Watts TH
Immunol Rev; 2009 May; 229(1):192-215. PubMed ID: 19426223
[TBL] [Abstract][Full Text] [Related]
14. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
16. Adoptively transferred tumor-specific T cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity in vivo.
Yi KH; Nechushtan H; Bowers WJ; Walker GR; Zhang Y; Pham DG; Podack ER; Federoff HJ; Tolba KA; Rosenblatt JD
Cancer Res; 2007 Oct; 67(20):10027-37. PubMed ID: 17942937
[TBL] [Abstract][Full Text] [Related]
17. Comment on "Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells".
Schwanninger A; Weinberger B; Grubeck-Loebenstein B
J Immunol; 2007 Mar; 178(5):2611-2; author reply 2612. PubMed ID: 17312097
[No Abstract] [Full Text] [Related]
18. Exploiting 4-1BB costimulation for enhancing antiviral vaccination.
Harrison JM; Bertram EM; Ramshaw IA
Viral Immunol; 2006; 19(4):593-601. PubMed ID: 17201654
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
[TBL] [Abstract][Full Text] [Related]
20. TNF family ligands define niches for T cell memory.
Sabbagh L; Snell LM; Watts TH
Trends Immunol; 2007 Aug; 28(8):333-9. PubMed ID: 17597006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
